FierceBiotechOriginal article
{"a":[{"_":"Scancell to go public after winning reverse merger bid for troubled Neuphoria","$":{"href":"/biotech/scancell-go-public-after-winning-reverse-merger-bid-troubled-neuphoria","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Scancell completed a reverse merger with Neuphoria, gaining a Nasdaq listing and resolving Neuphoria's shareholder situation following the biotech's closure of its social anxiety program.
Outcome Details
Reverse merger completed resulting in Nasdaq listing for Scancell
Importance:7/10
Sentiment:
0.60
M&Areverse mergerIPONasdaq listing
Related Companies
Read the original article
Published by FierceBiotech on July 23, 2026 10:17 AM